Market revenue in 2023 | USD 35,960.0 million |
Market revenue in 2030 | USD 61,724.4 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Chemotherapy |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.86% in 2023. Horizon Databook has segmented the Global home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global home infusion therapy market , including forecasts for subscribers. This global databook contains high-level insights into Global home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Application | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 12,787.1 | 13,626.1 | 15,467.4 | 17,620.2 | 18,950.2 | 20,216.7 | 21,620.8 | 23,207.9 | 24,933.9 | 26,812.4 | 28,839.5 | 31,047.7 | 33,448.5 | 7.5% |
Europe | 5,034.5 | 5,426.9 | 6,231.4 | 7,180.6 | 7,811.6 | 8,429.5 | 9,118.6 | 9,900.4 | 10,758.7 | 11,701.8 | 12,732.1 | 13,864.4 | 15,108.1 | 8.7% |
Asia Pacific | 2,997.5 | 3,273.4 | 3,806.6 | 4,441.0 | 4,889.8 | 5,339.0 | 5,842.2 | 6,414.5 | 7,047.4 | 7,747.6 | 8,514.4 | 9,365.5 | 10,305.9 | 9.9% |
Latin America | 819.1 | 859.0 | 959.1 | 1,074.2 | 1,135.4 | 1,189.8 | 1,249.2 | 1,315.7 | 1,386.2 | 1,460.9 | 1,537.6 | 1,619.6 | 1,705.7 | 5.3% |
MEA | 534.7 | 561.8 | 628.6 | 705.5 | 747.3 | 785.0 | 826.2 | 872.4 | 921.5 | 973.9 | 1,032.1 | 1,092.0 | 1,156.3 | 5.7% |
Overall | 22,172.8 | 23,747.1 | 27,093.1 | 31,021.5 | 33,534.3 | 35,960.0 | 38,657.0 | 41,710.8 | 45,047.7 | 48,696.6 | 52,655.6 | 56,989.2 | 61,724.4 | 8.0% |
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account